多年来,梅特福林诱导的慢性腹被误诊为刺激性肠综合征
Monika Chaudhary1, Naresh K Midha1, Pankaj Sukhadiya1
1General Medicine, All India Institute of Medical Sciences, Jodhpur, IND.
Cureus
|April 24, 2024
概括
甲胺是一种常见的2型糖尿病药物,可以引起慢性腹. 这一案例凸显了考虑甲胺诱导的腹的重要性,以避免误诊和不必要的治疗.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲福明是治疗2型糖尿病的第一线疗法,因为它具有有效性,耐受性和成本效益.
- 它通过降低肝脏葡萄糖的产生和增强外围葡萄糖吸收来起作用.
- 包括腹在内的胃肠道副作用很常见,并且与肠道微生物群变化,肠道葡萄糖变化和胆汁盐再吸收有关.
研究的目的:
- 在服用甲福明的患者中报告慢性腹被误诊为易怒肠综合征的病例.
- 强调考虑甲胺诱导的腹作为糖尿病患者出现慢性胃肠道症状的潜在诊断的重要性.
主要方法:
- 一个62岁的男性患者患有2型糖尿病的病例报告.
- 审查患者的病史,调查和对停止使用甲福明的反应.
主要成果:
- 患者经历了慢性腹和体重减轻六年后开始服用甲福林.
- 最初的调查结果不确切,导致误诊易怒肠综合征.
- 停用甲福明导致胃肠道症状显著改善.
结论:
- 在2型糖尿病患者中,甲胺诱导的慢性腹可能是显著的副作用.
- 早期考虑这种副作用可以防止广泛的调查和错误诊断.
- 认识到甲福明的潜在胃肠道影响对于患者的管理和福祉至关重要.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
157
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
157
Irritable Bowel Syndrome I: Introduction
272
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
272
Drugs for Treatment of Diarrhea-Predominant IBS
161
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161
Chronic Bowel Disorders: Introduction
446
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
446
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
118
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
118


